TREATMENT OF MULTIDRUG-RESISTANT NEPHROTIC SYNDROME (MDR-NS) IN CHILDREN
摘要
The present disclosure provides compositions and methods for treating multidrug-resistant nephrotic syndrome (MDR-NS) in pediatric subjects comprising atrasentan. Methods of reducing proteinuria in a pediatric patient having MDR-NS are also provided.
申请公布号
WO2017011772(A1)
申请公布日期
2017.01.19
申请号
WO2016US42567
申请日期
2016.07.15
申请人
ABBVIE, INC.
发明人
BRENNAN, John, J.;SCHAEFER, Franz;WIGDERSON, Melissa, E.
